Cochrane Insurance Medicine is implementing a survey to help identify topics that require evidence syntheses and further primary research.  Findings from the survey will be used to inform Cochrane about priority topics for conducting new systematic reviews and will inform researchers on urgent areas for primary research. Please contact Steve McCrosky for more information.

These collaborative, multi-topic research groups will play a crucial role in delivering trusted Cochrane evidence to address major global health challenges.  Learn more here.

Webinar presented by Cochrane TrainingAdvancements in AI, automation, and language processing are increasingly influencing the creation and use of evidence syntheses. AI language models (e.g., ChatGPT, Claude) and automation tools (e.g., ASReview, Laser AI, DistillerSR) offer new possibilities for tasks like search strategy development, screening and data extraction, risk of bias assessment, and writing evidence syntheses. These tools can significantly speed up the process of producing or updating evidence syntheses, benefiting researchers and users alike.

A unique opportunity for colleagues across the globe to get involved in evidence-based practice, with a shared miss

We are pleased to present our 2023 Annual Report, which aims to inform you about the main developments and progress of Cochrane's new thematic group ‘Work, Health and Social Security’.

This EUMASS symposium took a look at the op

“Insurance Medicine 2.0 in a changing world”. EUMASS 2023, Strasbourg (France) Sept 28-30 Don’t miss one of the key conferences in Insurance Medicine in EUROPE. This biannual congress organised by EUMASS (European Union of Medicine in Assurance and Social Security) offers opportunities for practitioners, researchers, and stakeholders to meet up and share knowledge. Click here for more information.

With a great pleasure we present the first Newsletter 2023. The past year was marked by many internal changes. Nevertheless, we were able to travel again, attend meetings and make new contacts.

As yet, interventions aiming to influence physicians’ sickness certification practice have not been evaluated scientifically. Studies in this field differ considerably concerning intervention content and effect measures. Against this background, in our meta-analysis we observed no statistically significant effect in favor of the interventions for having any return to work (RTW, i.e. first, partial, or full) nor full RTW.

Work participation is an outcome measured frequently in international research and across disciplines, but definitions and measurement methods vary substantially between trials. Consensus needs to be reached on key work participation outcomes, terminology and clinimetrically-sound measurement methods. Click here to read the